Evidence map›Paper›PMID 37916836›Full record

ArticleJournal of virology2023

The bipartite promoter of

Naoki Saka, Keisuke Ohta, Daniel Kolakofsky, Machiko Nishio

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Naoki SakaDepartment of Microbiology, School of Medicine, Wakayama Medical University , Wakayama, Japan.ORCID 0000-0002-9203-3306
Keisuke OhtaDepartment of Microbiology, School of Medicine, Wakayama Medical University , Wakayama, Japan.ORCID 0000-0003-4317-7407
Daniel KolakofskyDepartment of Microbiology and Molecular Medicine, University of Geneva School of Medicine , Geneva, Switzerland.
Machiko NishioDepartment of Microbiology, School of Medicine, Wakayama Medical University , Wakayama, Japan.ORCID 0000-0002-5311-5798
Wakayama Medical University · JPUniversity of Geneva · CH

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) JP22K15476Wakayama Medical University
6 · The paper itself

Abstract

importanceThe realization that segmented negative-strand RNA virus genome ribonucleoproteins are never free as their RNA ends are always bound to the viral polymerase has highlighted the problem of how these genome segments are replicated and express their mRNAs while their RNA ends remain associated with the polymerase throughout the cycles of RNA synthesis. This study of the length and nucleotide composition of the

Indexed as

NairovirusRNA VirusesNucleotidesPromoter Regions, GeneticRNA, Double-StrandedRNA, MessengerRNA, ViralNucleotidesRNA, Double-StrandedRNA, MessengerRNA, ViralL segmentOrthonairovirus hazaraensepromoter elementRNA synthesisuntranslated region

Identifiers

PMID37916836
PMCPMC10688357
OpenAlexW4388233076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.